Results

Total Results: 3,080 records

Showing results for "drugs".

141. Final Progress Report: Do Safety Warnings Change Prescribing Among the US Dialysis Population? (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/thamer-report.pdf
     January 01, 2024 - (FDA) outlining new safety information about erythropoiesis- stimulating agents (ESAs), widely used drugs … Conversely, use of other intravenous drugs continued to increase in 2008: 12% for IV vitamin D, 4.8% … [http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf] 29. … http://www.usrds.org/adr.htm http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf Principal … Office of Inspector General: Medicare Reimbursement for Existing End-stage Renal Disease Drugs.

142. Navigating the Health Care System | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/patient-involvement/navigating-the-health-care-system.html
     September 01, 2015 - Right for You How To Complain - And Get Heard Why It's Wise to Use a Health Advocate Off-Label Drugs

143. PowerPoint Presentation
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/surgery/49-multimodal-analgesia.pptx
     June 01, 2023 - for Improving Surgical Care and Recovery 1 Defining Multimodal Analgesia Combination of analgesic drugs … Improving Surgical Care and Recovery 2 Multimodal Analgesia Strategies Nonsteroidal anti-inflammatory drugs

144. 6 Tk1 T2-Talking With Residents Family Members Final (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T2-Talking_with_Residents_Family_Members_Final.pdf
     October 01, 2016 - If your family member takes other medications, sometimes the antibiotic might interact with certain drugs … previous antibiotics (and which ones if possible) • Previous antibiotic-resistant infections • Other drugs … Food and Drug Administration at http://www.fda.gov/Drugs/ResourcesForYou/ Consumers/BuyingUsingMedicineSafely … Prevention at http://www.cdc.gov/getsmart/community/for-patients/index.html http://www.fda.gov/Drugs … 0bConsumers/BuyingUsingMedicineSafely/AntibioticsandAntibioticResistance/default.htm http://www.fda.gov/Drugs

145. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects.pdf
     April 01, 2022 - ) � Hemodynamic monitoring � Poor venous access � Long-term antibiotics � Vesicants or irritant drugs … Hemodynamic monitoring: Off Poor venous access: Off Long-term antibiotics: Off Vesicants or irritant drugs

146. Learn From Defects Tool Worksheet: Central Line-Assoiated Bloodstsream Infection (CLABSI) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/clabsi-learning-from-defects-revised.pdf
     April 01, 2022 - ) � Hemodynamic monitoring � Poor venous access � Long-term antibiotics � Vesicants or irritant drugs … Hemodynamic monitoring: Off Poor venous access: Off Long-term antibiotics: Off Vesicants or irritant drugs

147. Structured Communication about Warfarin and Patient Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/chain/practice-tools/warfarin-1-slides.pdf
     March 19, 2017 - Many drugs interact with warfarin. … The most common drugs that interact with warfarin are antibiotics. … These are drugs like ibuprofen, naproxen, and celecoxib. … antiinflammatory drugs]. … These are drugs like ibuprofen, naproxen, and celecoxib.

148. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=461
     January 01, 2024 - strategies that the FDA can use to approve and influence the post-approval prescribing of specialty drugs … , including expediting the drugs' availability to patients through expanded access programs and expedited … approval pathways, limiting the scope of the drugs' indications, and encouraging the development of … companion diagnostic tests to indicate which patients should receive the drugs. … Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs

149. SNAC Member: Yanling Yu, Ph.D. | Agency for Healthcare Research and Quality
     www.ahrq.gov/cpi/about/nac/snac-yu.html
     December 01, 2021 - Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee. Dr.

150. Data Visualizations | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/data-visualization/index.html
     September 01, 2023 - Hospitalizations Influenza Injuries Mental Disorders Mental Health Nursing Homes Opioids Poverty Prescription Drugs

151. Data Visualizations | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/data-visualization/index.html?page=0
     September 01, 2023 - Hospitalizations Influenza Injuries Mental Disorders Mental Health Nursing Homes Opioids Poverty Prescription Drugs

152. Final Progress Report: The elderly and OTC labeling information: A randomized controlled experiment test (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/16801-Sangasubana-draft-1.pdf
     February 28, 2010 - Context: During the past three decades, risk perceptions of drugs have not been studied extensively; … even fewer studies have targeted OTC drugs specifically (Sangasubana, 2003; Strutton et al., 1992). … Drugs & Aging, 22:361-70. Jacoby J, Kaplan LB. (1972). … “Nonprescription drugs and the elderly.” American Family Practitioner, June:175-9. … “Prescription to over-the-counter switching of drugs.”

153. Final Progress Report: Improving Medication Safety Across Clinical Settings (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
     January 01, 2024 - However, though these new agents have better side effect profiles than many of the older drugs, the … The most commonly used drugs in the library were vasopressors, diuretics, and propofol. … Drugs being given with no documented order were frequent and were not included as potential ADEs in … The most common types of error were incorrect dosing of titratable drugs and incorrect IV drug rates … May 20, 2002 “Drugs and Information Technology: What’s Next?”

154. Appendix, MATCH Resources for Patients | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/resources/match/matchap12.html
     August 01, 2012 - http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm296593.htm—Includes tips you can use to find out … protecting the public's health by assuring the safety, efficacy, and security of human and veterinary drugs

155. newbref
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/instructor/fundamentals/module5/slsitmonitor.pptx
     February 03, 2006 - 5 2.0 Page ‹#› Situation Monitoring 9 I = Illness M = Medication S = Stress A = Alcohol and Drugs … Matthews, the Team Leader, is calling out orders for drugs, X-rays, and labs.

156. Safe Medication Administration: Slide Presentation | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/labor-delivery/perinatal-care/modules/strategies/medication/safe-medication-slides.html
     July 01, 2023 - unit to consider as it establishes its processes for ensuring safe medication administration of these drugs … Slide 4: High-Alert Medications 1 High-alert medications are "drugs that bear a heightened risk … Although mistakes are not necessarily more common with these drugs, the consequences of errors are more … to reduce the risk of errors, such as the following: Improving access to information about these drugs

157. NAC Member: Yanling Yu Biography | Agency for Healthcare Research and Quality
     www.ahrq.gov/cpi/about/organization/nac/yu.html
     March 01, 2020 - Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee. Dr.

158. Final Progress Report: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/18372-LoRe-draft-1.pdf
     October 01, 2016 - Safety of newly approved drugs: implications for prescribing. JAMA 2002;287:2273-5. 4. … Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed. … Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. … Acute liver failure due to drugs. Semin Liver Dis 2008;28:175-87. 55. Bjornsson E, Olsson R. … Accessed at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM362444.pdf.

159. Appendix C. Glossary and Abbreviations | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/final-reports/prospectscare/prospectsapc.html
     April 01, 2020 - registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs … number, called the National Drug Code (NDC), which serves as a universal product identifier for human drugs … in the context of family and community. 25 RxNorm —RxNorm provides normalized names for clinical drugs … Food and Drug Administration, http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm .

160. 213. Specific Populations and Other Topics (Continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide213.html
     October 01, 2014 - interactions (See section in Chapter 6: Interactions of first-line tobacco use medications with other drugs